Hubei Biocause Pharmaceutical Co., Ltd.

SZSE:000627.SZ

3.1 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998199719961995
Revenue 49,725.82349,615.69549,583.19143,575.98750,192.08430,950.84453,405.5816,995.546541.107806.443967.951779.7361,133.7631,261.159964.603909.282835.759560.754518.725463.046422.679348.61356.012321.963255.863192.314237.532143.72483.266
Cost of Revenue 9,829.6348,458.5587,311.6173,225.1468,172.6312,866.9384,036.641,788.501517.972829.793977.503753.2221,111.7781,185.832866.155835.104726.057475.618451.059410.573380.848268.667261.152240.16193.047155.312176.37198.17453.942
Gross Profit 39,896.18941,157.13742,271.57340,350.8442,019.45428,083.90749,368.9415,207.04523.135-23.35-9.55226.51421.98675.32798.44874.179109.70285.13567.66652.47341.8379.94394.8681.80462.81637.00261.16145.5529.324
Gross Profit Ratio 0.8020.830.8530.9260.8370.9070.9240.8950.043-0.029-0.010.0340.0190.060.1020.0820.1310.1520.130.1130.0990.2290.2660.2540.2460.1920.2570.3170.352
Reseach & Development Expenses 00005.66219.22115.53811.4216.8386.5376.55.9767.9735.514000000000000000
General & Administrative Expenses 1,765.119333.971541.056628.195600.752500.292498.724550.04318.34312.9415.0511.92221.90921.45942.86649.85840.35432.48533.99432.34949.67942.31314.9369.77821.8088.8468.2218.2545.682
Selling & Marketing Expenses 423.079448.028684.949406.13596.878201.446275.208160.76714.29313.5912.85211.22811.7687.3839.1166.85312.23311.78713.56317.57532.27513.27415.73312.23613.0453.3841.241.4510.853
SG&A 1,765.119333.971541.056628.195600.752500.292498.724550.04332.63626.53127.90223.15133.67728.84251.98256.71152.58744.27247.55749.92481.95455.58730.66922.01434.85312.239.4619.7066.535
Other Expenses -48,509.579,825.5339,896.82836,146.50430,062.054-24,280.274-23,688.297-6,190.3883.1168.3113.1551.4530.2729.8346.0135.0265.98810.3154.7369.4821.5062.5838.2997.33220.60711.9315.6466.631.992
Operating Expenses -48,509.5710,159.50510,437.88536,774.69930,668.4672,614.66826,760.956,911.44479.62770.88173.64463.88480.2167.87752.83458.9655.38345.93249.3350.75983.36856.96144.98136.55736.16212.9759.97410.3236.803
Operating Income 1,216.25431,188.83232,917.0343,881.54312,052.7822,653.5732,727.3913,424.804332.193101.066-141.10614.91-113.67422.2253.1962.287106.43353.1268.22-1.719-45.07315.83957.47648.28141.76530.70563.07848.59330.778
Operating Income Ratio 0.0240.6290.6640.0890.240.0860.0510.2020.6140.125-0.1460.019-0.10.0180.0550.0030.1270.0950.016-0.004-0.1070.0450.1610.150.1630.160.2660.3380.37
Total Other Income Expenses Net -1,868.039-30,964.053-32,573.911-2,432.081-8,419.338-18,306.339-4,428.255-1,585.5390.925203.182-45.36952.367-58.45523.61213.595-7.90558.10213.245-14.430.538-9.514-9.079-0.249-3.146.12612.8336.60310.0646.22
Income Before Tax -1,868.039224.778343.1231,449.4613,633.4442,636.352,724.3073,432.561334.433108.951-128.56414.997-116.67831.06159.2097.313112.42157.9458.4315.007-47.30916.16257.70248.8647.57639.74863.25750.25630.755
Income Before Tax Ratio -0.0380.0050.0070.0330.0720.0850.0510.2020.6180.135-0.1330.019-0.1030.0250.0610.0080.1350.1030.0160.011-0.1120.0460.1620.1520.1860.2070.2660.350.369
Income Tax Expense -1,216.254-285.842-537.095331.556714.891259.0946.02323.71983.89524.834-28.1151.191-9.4991.9763.915-0.07420.474.8140.3290.0721.7398.33611.0018.51112.1999.2478.48413.367.988
Net Income -651.785510.62880.2181,117.9062,918.5531,326.521,326.1641,778.719247.26783.823-101.01111.825-101.68428.32255.762-23.81889.70848.3667.0995.09-48.1065.26137.22734.24331.34330.2354.77336.89622.767
Net Income Ratio -0.0130.010.0180.0260.0580.0430.0250.1050.4570.104-0.1040.015-0.090.0220.058-0.0260.1070.0860.0140.011-0.1140.0150.1050.1060.1220.1570.2310.2570.273
EPS -0.130.10.180.230.590.270.30.440.180.06-0.0750.009-0.0750.0210.037-0.0190.0910.0450.0070.004-0.0820.0040.0260.0260.0220.0210.0490.0330.039
EPS Diluted -0.130.10.180.230.590.270.30.440.180.06-0.0750.009-0.0750.0210.037-0.0190.0910.0450.0070.004-0.0820.0040.0260.0260.0220.0210.0490.0330.039
EBITDA 1,216.25431,336.10233,050.973,945.20512,131.95228,778.09724,639.048,786.242556.822301.645-1.202119.594-18.297133.419136.39354.688130.436109.71660.32454.8122.3764.11495.96585.82951.72637.09651.18735.22722.521
EBITDA Ratio 0.0240.6320.6670.0910.2420.930.4610.5171.0290.374-0.0010.153-0.0160.1060.1410.060.1560.1960.1160.1180.0060.1840.270.2670.2020.1930.2150.2450.27